Queen Mary School, Nanchang University, Nanchang, Jiangxi, 330031, People's Republic of China.
Aging and Vascular Diseases, Human Aging Research Institute (HARI) and School of Life Science, Nanchang University, and Jiangxi Key Laboratory of Human Aging, Nanchang, Jiangxi, 330031, People's Republic of China.
Clin Interv Aging. 2023 Aug 17;18:1373-1395. doi: 10.2147/CIA.S423373. eCollection 2023.
Vascular aging represents a collection of structural and functional changes in a blood vessel with advancing age, including increased stiffness, vascular wall remodeling, loss of angiogenic ability, and endothelium-dependent vasodilation dysfunction. These age-related alterations may occur earlier in those who are at risk for or have cardiovascular diseases, therefore, are defined as early or premature vascular aging. Vascular aging contributes independently to cardio-cerebral vascular diseases (CCVDs). Thus, early diagnosis and interventions targeting vascular aging are of paramount importance in the delay or prevention of CCVDs. Here, we review the direct assessment of vascular aging by examining parameters that reflect changes in structure, function, or their compliance with age including arterial wall thickness and lumen diameter, endothelium-dependent vasodilation, arterial stiffness as well as indirect assessment through pathological studies of biomarkers including endothelial progenitor cell, lymphocytic telomeres, advanced glycation end-products, and C-reactive protein. Further, we evaluate how different types of interventions including lifestyle mediation, such as caloric restriction and salt intake, and treatments for hypertension, diabetes, and hyperlipidemia affect age-related vascular changes. As a single parameter or intervention targets only a certain vascular physiological change, it is recommended to use multiple parameters to evaluate and design intervention approaches accordingly to prevent systemic vascular aging in clinical practices or population-based studies.
血管衰老代表了血管随年龄增长而发生的一系列结构和功能变化,包括僵硬度增加、血管壁重构、血管生成能力丧失和内皮依赖性血管舒张功能障碍。这些与年龄相关的改变可能在心血管疾病风险增加或已经患有心血管疾病的人群中更早发生,因此被定义为早期或过早的血管衰老。血管衰老是导致心脑血管疾病(CCVDs)的独立因素。因此,针对血管衰老的早期诊断和干预对于延缓或预防 CCVDs 至关重要。在这里,我们通过检查反映结构、功能变化或与年龄相关的顺应性的参数,直接评估血管衰老,包括动脉壁厚度和管腔直径、内皮依赖性血管舒张、动脉僵硬度以及通过生物标志物的病理学研究进行间接评估,包括内皮祖细胞、淋巴细胞端粒、晚期糖基化终产物和 C 反应蛋白。此外,我们评估了包括生活方式干预(如热量限制和盐摄入量)以及高血压、糖尿病和高脂血症治疗在内的不同类型的干预措施如何影响与年龄相关的血管变化。由于单个参数或干预措施仅针对特定的血管生理变化,因此建议使用多个参数进行评估,并相应地设计干预方法,以防止临床实践或基于人群的研究中的系统性血管衰老。